FibroBiologics Inc (FBLG)
2.60
+0.19
(+7.88%)
USD |
NASDAQ |
Nov 22, 16:00
2.59
-0.01
(-0.38%)
After-Hours: 20:00
FibroBiologics Market Cap: 90.11M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 90.11M |
| November 21, 2024 | 83.53M |
| November 20, 2024 | 77.64M |
| November 19, 2024 | 82.49M |
| November 18, 2024 | 86.82M |
| November 15, 2024 | 89.42M |
| November 14, 2024 | 97.39M |
| November 13, 2024 | 106.75M |
| November 12, 2024 | 109.87M |
| November 11, 2024 | 119.57M |
| November 08, 2024 | 126.18M |
| November 07, 2024 | 121.09M |
| November 06, 2024 | 121.43M |
| November 05, 2024 | 110.23M |
| November 04, 2024 | 103.11M |
| November 01, 2024 | 107.86M |
| October 31, 2024 | 102.43M |
| October 30, 2024 | 100.06M |
| October 29, 2024 | 93.27M |
| October 28, 2024 | 95.65M |
| October 25, 2024 | 96.67M |
| October 24, 2024 | 97.68M |
| October 23, 2024 | 95.99M |
| October 22, 2024 | 97.68M |
| October 21, 2024 | 103.62M |
| Date | Value |
|---|---|
| October 18, 2024 | 114.98M |
| October 17, 2024 | 112.61M |
| October 16, 2024 | 109.89M |
| October 15, 2024 | 93.27M |
| October 14, 2024 | 91.58M |
| October 11, 2024 | 88.19M |
| October 10, 2024 | 78.69M |
| October 09, 2024 | 87.51M |
| October 08, 2024 | 93.27M |
| October 07, 2024 | 93.95M |
| October 04, 2024 | 96.33M |
| October 03, 2024 | 89.88M |
| October 02, 2024 | 90.90M |
| October 01, 2024 | 98.36M |
| September 30, 2024 | 104.81M |
| September 27, 2024 | 112.48M |
| September 26, 2024 | 110.71M |
| September 25, 2024 | 96.96M |
| September 24, 2024 | 102.96M |
| September 23, 2024 | 97.32M |
| September 20, 2024 | 116.36M |
| September 19, 2024 | 111.42M |
| September 18, 2024 | 114.24M |
| September 17, 2024 | 115.30M |
| September 16, 2024 | 114.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
39.03M
Minimum
Aug 16 2024
945.52M
Maximum
Jan 31 2024
227.70M
Average
179.67M
Median
Jul 29 2024
Market Cap Benchmarks
| Charles River Laboratories International Inc | 10.01B |
| CEL-SCI Corp | 36.64M |
| AIM ImmunoTech Inc | 13.38M |
| IGC Pharma Inc | 27.57M |
| NovaBay Pharmaceuticals Inc | 3.327M |
Market Cap Related Metrics
| Price to Book Value | 32.92 |
| Price | 2.60 |
| Earnings Yield | -21.12% |